Health Condition 1: F400- Agoraphobia Health Condition 2: F064- Anxiety disorder due to known physiological condition Health Condition 3: F419- Anxiety disorder, unspecified Health Condition 4: F411- Generalized anxiety disorder Health Condition 5: F413- Other mixed anxiety disorders Health Condition 6: F418- Other specified anxiety disorders Health Condition 7: F410- Panic disorder [episodic paroxysmal anxiety] Health Condition 8: F940- Selective mutism Health Condition 9: F930- Separation anxi
Conditions
Interventions
None listed
Sponsors
Dr Dnyaneshwar Kurle
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient with the age from 18 to 65 years diagnosed with anxiety disorder according to DSM V criteria of either sex will be included. 2. Patients and legal authorized representative willing to give informed consent and participate in the study. 3. Patient who are able to understand and do the computerized psychometric test. 4. Patients who are able to read or understand the prescriptions and pronounce the names of the drugs correctly.
Exclusion criteria
Exclusion criteria: 1. Patients unwilling to participate 2. Pregnant or lactating patients. 3. Patients already receiving treatment for anxiety disorder 4. Patients admitted in Psychiatry IPD or emergency department. 5. Patients receiving treatment for any psychotic disorder such as schizophrenia, Alzheimerâ??s Syndrome or dementia or for substance abuse disorder. 6. Patients unable to perform the computerized psychometric tests after training session 7. Patients who suffer excessive stress and test anxiety during computerized psychometric testing 8. Patients who are not able to read or understand the prescriptions and pronounce the names of the drugs correctly. 9. Patients with serious diseases such as heart failure, chronic kidney disease or with suicidal ideation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in psychometric function test scores over a 6 week periodTimepoint: Immediately and at follow up after 6 weeks, 18 month duration | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in anxiety rating scores over a 6 week periodTimepoint: Immediately and at follow up after 6 weeks, 18 month duration;Cost of drugs for treatment of anxiety disorders in patientsTimepoint: Single point, 18 month duration;Drugs prescribed for treatment of anxiety disorders in patientsTimepoint: Single point, 18 month duration;Level of disease and drug treatment awareness amongst patients with anxiety disorderTimepoint: Single point, 18 month duration | — |
Countries
India
Contacts
Public ContactDr Dnyaneshwar Kurle
Seth G.S. Medical College and K.E.M. Hospital, Parel, Mumbai
Outcome results
None listed